PCLAF and lung adenocarcinoma: In addition, we assessed whether we could predict the survival of patients with LUAD based on the expression of KIAA0101. The discovery of the gene regulatory network of KIAA0101 will open new avenues for further studies on the epigenetics of KIAA0101. The study of immune infiltration related to KIAA0101 will provide new directions for immunotherapy of lung adenocarcinoma.